Naproxen Viatris (Naproxen)

Naproxen works by non‑selectively inhibiting the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes. This inhibition reduces the production of prostaglandins, which are key mediators of inflammation, pain, and fever, thereby providing analgesic, anti‑inflammatory, and antipyretic effects.

The appropriate dose of Naproxen Viatris is determined by the prescribing healthcare professional based on the specific indication, patient age, weight, and clinical response. Patients should follow the prescriber’s instructions and never adjust the dose on their own.

Safety of naproxen during pregnancy or lactation has not been definitively established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity of Naproxen Viatris. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Naproxen generally has a longer half‑life than ibuprofen, allowing for less frequent dosing. Both drugs share similar mechanisms of COX inhibition, but naproxen may have a slightly lower cardiovascular risk profile, while ibuprofen may be preferred for short‑term, low‑dose use. Choice depends on individual patient factors and clinician judgment.

Store Naproxen Viatris at room temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight, and excessive heat to maintain stability and potency throughout its shelf life.

Naproxen Viatris is taken orally, usually with a full glass of water. It can be taken with or without food; however, taking it with food or milk may reduce gastrointestinal discomfort. Patients should swallow tablets whole and not crush or chew them.

The most serious risks include gastrointestinal bleeding or ulcer perforation, serious cardiovascular events such as heart attack or stroke, renal impairment, and severe skin reactions like Stevens‑Johnson syndrome. Patients should be monitored for signs of these conditions and seek immediate medical attention if they occur.

Naproxen Viatris should be avoided in individuals with known hypersensitivity to naproxen or other NSAIDs, active gastrointestinal ulceration, severe renal or hepatic impairment, and in patients with established cardiovascular disease who are at high risk for thrombotic events. A healthcare professional should evaluate suitability before prescribing.